Osteogenesis imperfecta

JC Marini, WA Cabral - Genetics of bone biology and skeletal disease, 2018 - Elsevier
Osteogenesis imperfecta is a genetic disorder characterized by low bone mass, decreased
bone strength, increased bone fragility, and shortened stature. Autosomal dominant …

Mechanisms of bone fragility: from osteogenesis imperfecta to secondary osteoporosis

A El-Gazzar, W Högler - International Journal of Molecular Sciences, 2021 - mdpi.com
Bone material strength is determined by several factors, such as bone mass, matrix
composition, mineralization, architecture and shape. From a clinical perspective, bone …

Molecular insights into prolyl and lysyl hydroxylation of fibrillar collagens in health and disease

RAF Gjaltema, RA Bank - Critical reviews in biochemistry and …, 2017 - Taylor & Francis
Collagen is a macromolecule that has versatile roles in physiology, ranging from structural
support to mediating cell signaling. Formation of mature collagen fibrils out of procollagen α …

[HTML][HTML] What is new in genetics and osteogenesis imperfecta classification?

ER Valadares, TB Carneiro, PM Santos… - Jornal de …, 2014 - SciELO Brasil
OBJECTIVE: Literature review of new genes related to osteogenesis imperfecta (OI) and
update of its classification. SOURCES: Literature review in the PubMed and OMIM …

The evolution of the nosology of osteogenesis imperfecta

M Chetty, IA Roomaney, P Beighton - Clinical Genetics, 2021 - Wiley Online Library
Osteogenesis imperfecta (OI) is a relatively common genetic skeletal disorder with an
estimated frequency of 1 in 20 000 worldwide. The manifestations are diverse and although …

Biallelic variants in four genes underlying recessive osteogenesis imperfecta

A Hayat, S Hussain, M Bilal, M Kausar… - European journal of …, 2020 - Elsevier
Osteogenesis imperfecta (OI) is an inherited heterogeneous rare skeletal disorder
characterized by increased bone fragility and low bone mass. The disorder mostly …

Cellular stress due to impairment of collagen prolyl hydroxylation complex is rescued by the chaperone 4-phenylbutyrate

R Besio, N Garibaldi, L Leoni… - Disease models & …, 2019 - journals.biologists.com
Osteogenesis imperfecta (OI) types VII, VIII and IX, caused by recessive mutations in
cartilage-associated protein (CRTAP), prolyl-3-hydroxylase 1 (P3H1) and cyclophilin B …

Molecular spectrum and differential diagnosis in patients referred with sporadic or autosomal recessive osteogenesis imperfecta

JA Caparros‐Martin, MS Aglan… - Molecular genetics & …, 2017 - Wiley Online Library
Background Osteogenesis imperfecta (OI) is a heterogeneous bone disorder characterized
by recurrent fractures. Although most cases of OI have heterozygous mutations in COL 1A1 …

Zoledronic acid in children with osteogenesis imperfecta and Bruck syndrome: a 2-year prospective observational study

GA Otaify, MS Aglan, MM Ibrahim, M Elnashar… - Osteoporosis …, 2016 - Springer
Treatment with zoledronic acid (ZA) over 2 years, among 33 children with osteogenesis
imperfecta (OI) and five Bruck syndrome cases, showed reduction in fracture rates, pain, and …

Mutations and altered expression of SERPINF1 in patients with familial otosclerosis

JL Ziff, M Crompton, HRF Powell, JA Lavy… - Human molecular …, 2016 - academic.oup.com
Otosclerosis is a relatively common heterogenous condition, characterized by abnormal
bone remodelling in the otic capsule leading to fixation of the stapedial footplate and an …